Literature DB >> 32865734

A Cross-Sectional Evaluation of Quality of Life Among Patients with Hepatic Adenomas.

Emily A Armstrong1, Aslam Ejaz1, Angela Sarna1, Lanla Conteh1, Allan Tsung1, Timothy M Pawlik1, Jordan M Cloyd2.   

Abstract

Entities:  

Year:  2020        PMID： 32865734     DOI： 10.1007/s11605-020-04780-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

1.  Improvements in quality of life after surgery for benign hepatic tumors: Results from a dual center analysis.

Authors:  Peter J Kneuertz; J Wallis Marsh; Mechteld C de Jong; Keaton Covert; Omar Hyder; Kenzo Hirose; Richard D Schulick; Michael A Choti; David A Geller; Timothy M Pawlik
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

2.  Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire.

Authors:  Nancy Heffernan; David Cella; Kimberly Webster; Linda Odom; Mary Martone; Steven Passik; Marilyn Bookbinder; Yuman Fong; William Jarnagin; Leslie Blumgart
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

3.  General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G).

Authors:  Penny S Brucker; Kathleen Yost; John Cashy; Kimberly Webster; David Cella
Journal:  Eval Health Prof       Date:  2005-06       Impact factor: 2.651

Review 4.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

Review 5.  The Use of Facebook in Recruiting Participants for Health Research Purposes: A Systematic Review.

Authors:  Christopher Whitaker; Sharon Stevelink; Nicola Fear
Journal:  J Med Internet Res       Date:  2017-08-28       Impact factor: 5.428
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.